Domain- und Website-Informationen:
Domainname - fanosin.de
Seitentitel - fanosin.de
Gehen Sie zur Webseite - fanosin.de
ns02.xidrasservice.com ns01.xidrasservice.com ns04.xidrasservice.com ns03.xidrasservice.com
☆ fanosin.de. 300 IN A 127.0.0.1
☆ fanosin.de. 3600 IN NS ns01.xidrasservice.com.
☆ fanosin.de. 3600 IN NS ns02.xidrasservice.com.
☆ fanosin.de. 3600 IN NS ns03.xidrasservice.com.
☆ fanosin.de. 3600 IN NS ns04.xidrasservice.com.
☆ fanosin.de. 300 IN SOA ns01.xidrasservice.com. domains.xidras.com. 1659542162 39940 14400 604800 3600
% Terms and Conditions of Use
% The above data may only be used within the scope of technical or
% administrative necessities of Internet operation or to remedy legal
% The use for other purposes, in particular for advertising, is not permitted.
% The DENIC whois service on port 43 doesn't disclose any information concerning
% the domain holder, general request and abuse contact.
% This information can be obtained through use of our web-based whois service
% available at the DENIC website:
Kurze Fakten über fanosin:
Famotidine, sold under the brand name Pepcid among others, is a histamine H₂ receptor antagonist medication that decreases stomach acid production. It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It is takenby mouth or by injection into a vein. It begins working within an hour. Common side effects include headache, intestinal upset, and dizziness. Serious side effects may include pneumonia and seizures. Use in pregnancy appears safe but has not been well studied while use during breastfeeding is not recommended. Famotidine was patented in 1979 and came into medical use in 1985. It is available as a generic medication. In 2019, it was the 104th most commonly prescribed medication in the United States, with more than 6 million prescriptions.
© DMS 2011-